Literature DB >> 33219425

Lipid profiles and their potential inflammatory effects in anti-N-methyl-D-aspartate receptor encephalitis.

Fei Liu1,2, Baojie Wang2, Chunjuan Wang1,3, Bingbing Zhang4, Shougang Guo5,6.   

Abstract

BACKGROUND: Growing evidence suggests an association between dyslipidemia and autoimmune diseases. This study aimed to perform a preliminary analysis to investigate the role of lipid profiles in anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis and to preliminarily explore the potential inflammatory effects of lipids on this disease by analyzing the association of lipid profiles with different inflammatory markers.
METHODS: This retrospective study consisted of 40 anti-NMDAR encephalitis patients and 74 healthy controls. Serum lipid profiles and different inflammatory markers were analyzed upon admission and at each follow-up. Lipid profiles were compared among subgroups of patients, which were divided according to clinical characteristics. Correlations between lipid profiles and different inflammatory markers were assessed.
RESULTS: The results showed that lipid profiles were abnormal and were correlated with both disease severity and prognosis in patients with anti-NMDAR encephalitis. Correlations between lipid profiles and different inflammatory markers were observed. After 12 months of treatment, inflammatory markers changed with lipid profiles, and these changes were significantly correlated.
CONCLUSIONS: Lipid profiles are associated with pathogenesis and progression of anti-NMDAR encephalitis, and they are significantly correlated with different inflammatory markers, suggesting that the association of lipids with the disease might be influenced by the inflammatory response.

Entities:  

Keywords:  Anti-NMDAR encephalitis; Inflammation; Lipid profiles; Mechanism; Treatment

Year:  2020        PMID: 33219425     DOI: 10.1007/s10072-020-04882-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  33 in total

1.  Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.

Authors:  Yan Zhang; Gang Liu; Mengdi Jiang; Weibi Chen; Yanbo He; Yingying Su
Journal:  Neurocrit Care       Date:  2018-10       Impact factor: 3.210

2.  Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain.

Authors:  Amy J Gleichman; Lynn A Spruce; Josep Dalmau; Steven H Seeholzer; David R Lynch
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

3.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

4.  Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

Authors:  Josep Dalmau; Erdem Tüzün; Hai-yan Wu; Jaime Masjuan; Jeffrey E Rossi; Alfredo Voloschin; Joachim M Baehring; Haruo Shimazaki; Reiji Koide; Dale King; Warren Mason; Lauren H Sansing; Marc A Dichter; Myrna R Rosenfeld; David R Lynch
Journal:  Ann Neurol       Date:  2007-01       Impact factor: 10.422

5.  Clinical characteristics and factors associated with short-term prognosis in adult patients with autoimmune encephalitis of non-neoplastic etiology.

Authors:  Xiaoyu Dong; Dongming Zheng; Jianfei Nao
Journal:  Neurol Sci       Date:  2019-04-07       Impact factor: 3.307

Review 6.  Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases.

Authors:  Margherita Nosadini; Shekeeb S Mohammad; Francesco Corazza; Ezia Maria Ruga; Kavitha Kothur; Giorgio Perilongo; Anna Chiara Frigo; Irene Toldo; Russell C Dale; Stefano Sartori
Journal:  Dev Med Child Neurol       Date:  2017-04-25       Impact factor: 5.449

7.  Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

Authors:  Nuria Gresa-Arribas; Maarten J Titulaer; Abiguei Torrents; Esther Aguilar; Lindsey McCracken; Frank Leypoldt; Amy J Gleichman; Rita Balice-Gordon; Myrna R Rosenfeld; David Lynch; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-12-18       Impact factor: 44.182

8.  Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis.

Authors:  Anjali Ganda; Martin Magnusson; Laurent Yvan-Charvet; Bo Hedblad; Gunnar Engström; Ding Ai; Thomas J Wang; Robert E Gerszten; Olle Melander; Alan R Tall
Journal:  Circulation       Date:  2013-02-01       Impact factor: 29.690

9.  Leukocyte activation by triglyceride-rich lipoproteins.

Authors:  Arash Alipour; Antonie J H H M van Oostrom; Alisa Izraeljan; Caroline Verseyden; Jennifer M Collins; Keith N Frayn; Thijs W M Plokker; Jan Willem F Elte; Manuel Castro Cabezas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-24       Impact factor: 8.311

10.  Serum complement levels in anti-N-methyl-d-aspartate receptor encephalitis.

Authors:  Y Shu; C Chen; Y Chen; Y Xu; Y Chang; R Li; X Sun; L Peng; Z Lu; W Qiu
Journal:  Eur J Neurol       Date:  2017-11-17       Impact factor: 6.089

View more
  2 in total

1.  Influential Factors, Treatment and Prognosis of Autoimmune Encephalitis Patients With Poor Response to Short-Term First-Line Treatment.

Authors:  Fei Liu; Bingbing Zhang; Teng Huang; Baojie Wang; Chunjuan Wang; Maolin Hao; Shougang Guo
Journal:  Front Neurol       Date:  2022-04-14       Impact factor: 4.003

2.  Simple and effective serum biomarkers potential for predicting status epilepticus in anti-N-methyl-D-aspartate receptor encephalitis.

Authors:  Yingying Liu; Lili Ma; Xiaomeng Ma; Xueying Ma; Jing Li; Donghong Li; Xiuli Lin; Zhumin Su; Xiaohong Chen
Journal:  BMC Neurol       Date:  2022-01-14       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.